ELVN
Enliven Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$27.77
-1.04 ▼ -3.61%
🌙 3월 13일 6:13 PM ET (한국 3/14 07:13)
$27.00
-0.77 ▼ -2.77%
| Index | RUT | P/E | - | EPS (ttm) | -1.86 | Insider Own | 27.06% | Shs Outstand | 0.06B | Perf Week | -5.67% |
| Market Cap | 1.66B | Forward P/E | - | EPS next Y | -37.34% | Insider Trans | -2.53% | Shs Float | 0.04B | Perf Month | -0.86% |
| Enterprise Value | 1.20B | PEG | - | EPS next Q | -0.44 | Inst Own | 82.06% | Short Float | 18.29% | Perf Quarter | 37.68% |
| Income | -0.10B | P/S | - | EPS this Y | -15.71% | Inst Trans | -0.52% | Short Ratio | 7.69 | Perf Half Y | 39.41% |
| Sales | 0.00B | P/B | 3.59 | EPS next 5Y | -27.69% | ROA | -25.86% | Short Interest | 7.98M | Perf YTD | 80.32% |
| Book/sh | 7.73 | P/C | 3.59 | EPS past 3/5Y | 46.65% 33.56% | ROE | -26.95% | 52W High | -10.36% ($30.98) | Perf Year | 36.87% |
| Cash/sh | 7.74 | P/FCF | - | Sales past 3/5Y | - | ROIC | -22.56% | 52W Low | 108.8% ($13.30) | Perf 3Y | 27.39% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 2.24% | Gross Margin | - | Volatility(W/M) | 6.79% 5.89% | Perf 5Y | -32.27% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.74 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 28.66 | EPS Q/Q | -2.58% | Profit Margin | - | RSI (14) | 48.06 | Recom | 1.12 |
| Dividend Gr. 3/5Y | - | Current Ratio | 28.66 | Sales Q/Q | - | SMA20 | -2.56% ($28.5) | Beta | 0.45 | Target Price | $39.57 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 5.79% ($26.25) | Rel Volume | 1.08 | Prev Close | $28.81 |
| Employees | 60 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -24.68% -100% | SMA200 | 28.11% ($21.68) | Avg Volume(3M) | 1.04M | Price | $27.77 |
| IPO | 2020/3/12 | Option/Short | Yes/Yes | Trades | 8157 | Volume | 1,120,236 | Change | -3.61% |
뉴스 로딩 중...